PT-141
FDA ApprovedBremelanotide
- Category
- Sexual Health
- Aliases
- Bremelanotide, Vyleesi
- Administration
- Subcutaneous injection (approved), Intranasal (research)
Timing
A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.
- 1
1–2 Weeks
Effects are typically felt within the same session, given the compound's fast onset — this window reflects the first several uses.
- 2
3–4 Weeks
Users generally know by now whether the compound produces a reliable effect for them.
- 3
5–7 Weeks
Regular users typically describe a consistent, predictable response with each use.
- 4
8–10 Weeks
No cumulative buildup is generally expected; effects remain tied to each individual dose.
- 5
11–15 Weeks
Consistent users often reassess dosing based on side effects like nausea experienced with continued use.
- 6
16–20 Weeks
Long-term users typically maintain a stable sense of what to expect from each dose.
- 7
21–24 Weeks
By this stage, most users have settled into a personal pattern of use based on their individual response.
⚠️ Research context only. This is not medical advice and results are not guaranteed.